Peripheral primary neuroectodermal tumors (PNET) are uncommon tumors, with an overall incidence of 1% of all sarcomas. Renal PNET is extremely rare. It is an aggressive tumor, with a high incidence of local recurrence and early metastases. Radiological diagnosis can be challenging as it is often difficult to differentiate it from other primary renal neoplasms. Imaging features include a large heterogeneous mass with central low density areas due to necrosis. Intra tumor hemorrhage and calcification are rare. We present a rare case of a large PNET mimicking renal cell carcinoma in a 51 year old female that required arterial embolization and nephrectomy.
gland and 6 para aortic lymph nodes were submitted for pathological examination.
Macroscopically, the kidney specimens showed a large lobulated tumor mass (Fig. 8) , located mostly at the upper pole, but also invading the lower pole, occupying more than 85% of the kidney parenchyma by visual estimation. Microscopically, the tumor was composed of uniform cells with little cytoplasm, arranged as broad sheets, having a somewhat organized trabeculae (Fig. 9) . Subtle pseudo rosette formation was identified. Tumor cells were present in the vasculature, with extension into the perihilar fat. Immunohistochemical stains were performed and stained positive for neuro-specific enolase and CD99 antigen.
A final pathologic diagnosis of primitive neuroectodermal tumor was made, and a second opinion (outside consultation) concurred with this diagnosis.
Primitive neuroectodermal tumors (PNETs) are a rare group of small round cell tumors, which are classified into two types based on location in the body: peripheral PNET and central nervous system (CNS) PNET. Hart and Earle first introduced the term PNET in 1973 to describe undifferentiated tumors of the cerebellum that did not match the diagnostic criteria for neuroblastoma, ependymoblastoma, medulloblastoma or pineal parenchymal tumors (1).
Peripheral PNET are uncommon, with an overall incidence of 1% of all sarcomas. The most common locations of peripheral PNETs have been the thoracopulmonary region, the retroperitoneal paravertebral soft tissues, the soft tissues of the head and neck, the intra-abdominal and intra-pelvic soft tissues, and extremities. The incidence of peripheral PNET in the abdomen and pelvis, including the retroperitoneum, is about 14% of all peripheral PNETs(2).
The peak age incidence (of peripheral PNETs) is in adolescence and young adulthood, but can occur at any age, with no gender predilection (2).
Renal PNET is an aggressive tumor, with a tendency towards local recurrence and early metastases to regional lymph nodes, lungs, liver, and bone. The overall 5-year disease-free survival rate is between 45 and 55%, but in patients with metastatic disease at initial presentation, the median relapse-free survival is only 2 years (3).
Grossly, PNET of the kidney are encapsulated and contain focal areas of hemorrhage and/or necrosis. The tumor is usually sharply demarcated from the normal kidney (4). Microscopically, the tumor consists of small round cells with indistinct cell borders. The latter gives a 'syncytial' appearance. Some tumor cells may arrange themselves as perivascular pseudo-rosettes or Homer-Wright rosettes (3). These tumors typically express high amounts of the MIC2 antigen (CD99), and exhibit highly characteristic chromosomal translocation between chromosome 11 and 22.They stain positive with neuron-specific enolase, which made them a distinct pathologic entity and differentiated them from other small round cell tumors, such as Ewing's sarcoma and neuroblastoma (2, 5) .
Radiological diagnosis of PNET of the kidney can be challenging as it is difficult to differentiate it from other primary renal neoplasms, such as Wilms' tumor and renal cell carcinoma.
CT scans show a large and heterogeneous mass with central low density areas due to necrosis. Areas of high attenuation within the tumor, due to hemorrhage, have been observed. There have been reports of tumor calcification which may be multiple, peripheral, or linear (3) and tumor extension into the renal vein, inferior vena cava, right atrium and ventricle. Hepatic metastases, when present, manifest as low attenuation lesions (6).
MRI shows a low-signal-intensity solid mass with lobulated contours on T1-weighted images. On T2-weighted images, the tumor has heterogeneous signal intensity, separated by irregular septa, which invariably enhance after contrast administration. The presence of peripheral necrosis and hemorrhage, rather than central necrosis, which is found in most large renal tumors, as a feature of renal PNETs (7).
Considering the age of our patient, the primary diagnosis was renal cell carcinoma (RCC). RCC is the most common renal malignancy in adults and should be the first consideration in an adult presenting with hematuria and a flank mass. RCC is a vascular tumor that can attain a large size, and contain hemorrhage and necrosis. Calcification occurs in 10% of RCC and vascular invasion is a well-known feature. The differential diagnosis for hypervascular renal mass includes leiomyosarcomas, which are rare mesenchymal tumors, accounting for over 50% of renal sarcomas. Sarcomas present as large, infiltrative renal masses on imaging. This appearance is non-specific, and diagnosis depends on the cellular components. Other tumors that may present as large infiltrative renal masses include transitional cell carcinomas, lymphoma and renal metastases. Although the epicenters of transitional cell carcinomas are expected to be in the renal pelvis or upper ureter, this may be difficult to ascertain if the tumor is large. Lymphoma should be suspected when there is concomitant bulky perinephric disease, widespread lymphadenopathy or when contralateral renal involvement is seen. Metastases to kidneys present as small, multifocal, bilateral renal masses in a patient with a known primary malignancy such as lung cancer (8,9).
Primitive neuroectodermal tumor is a rare primary tumor of the kidney. The imaging features are non specific and the definitive diagnosis is made by immunohistochemistry and electron microscopy, typically after surgical resection. 
DISCUSSION

Etiology
None Incidence 1% of all sarcomas Gender ratio None Risk factors None Age predilection Adolescence and young adulthood Treatment Nephrectomy and chemotherapy
Prognosis
The overall 5-year disease-free survival rate is 45-55% Imaging findings US: Hyperechoic with increased vascularity CT: Large and heterogeneous hypervascular mass with necrosis +/-calcification and Hemorrhage. Renal vein thrombus when mass large. MRI: Low T1W and heterogenous T2W with septation. Enhancement in arterial phase. 
